Something unusual is happening beneath the surface of the stock market.
On TV, everything still looks fine.
The news says “buy.” The indexes look safe.
Below the surface, a war is starting.
Big money is fleeing one group of stocks…
And piling into another.
This kind of split has only happened a handful of times in the last 125 years.
Each time, one side of the market eventually broke down hard.
But the other side? It made people very, very rich.
10x… 20x… even 30x winners.
We are at that breaking point right now.
I’m going on camera to show you exactly which side is which.
Stay sharp,
JC Parets, CMT
Founder, TrendLabs
Wednesday’s Featured News
The AI Land Grab: Why SMCI’s Drop Is Your Gain
By Jeffrey Neal Johnson. Publication Date: 2/25/2026.
Key Points
- Super Micro Computer continues to deliver record-breaking revenue growth as demand for artificial intelligence hardware infrastructure accelerates globally.
- Management is executing a strategic land grab to secure a massive customer base that will rely on their ecosystem for the next decade of computing.
- Super Micro Computer is pivoting to monetize high-margin liquid-cooling solutions that are essential for operating next-generation AI processors.
- Special Report: [Sponsorship-Ad-6-Format3]
Fear can cloud judgment on Wall Street. Over the past few months a wave of caution has gripped the artificial intelligence (AI) hardware sector. Investors increasingly worry that the “picks and shovels” trade—the strategy of buying companies that build the physical infrastructure for AI—is coming to an end. As a result, stock prices across the sector have slipped on anticipation of slower spending.
Yet a closer look at the numbers tells a different story. There is a sizable disconnect between market sentiment and business reality, and nowhere is that more obvious than with Super Micro Computer (NASDAQ: SMCI).
Skip Headlines Straight to Original Research (Ad)
Our investment research analysts are going to be releasing their next investment idea tomorrow morning, around 10:00 AM Eastern time.Add yourself to the distribution list here.
As of late February, Super Micro shares are trading in the $30–$32 range, well below their 52-week highs and signaling deep investor skepticism. Still, the company recently reported a record quarter, with revenue for the second quarter of fiscal 2026 reaching $12.68 billion.
That represents a staggering 123% increase year over year.
The company is not shrinking; it is expanding rapidly. The gap between this outsized revenue growth and the falling stock price has created an unusual situation: investors are fleeing because profit margins have tightened, but they may be missing the broader strategy. This margin compression appears not to be a sign of failure but a deliberate land grab aimed at securing a dominant position in the next decade of AI infrastructure.
The Cost of Dominance: Why Margins Are Down
To assess the opportunity, investors must first acknowledge the bad news. In the most recent quarter, Super Micro’s gross margin fell to 6.4%. Gross margin measures the percentage of revenue remaining after the direct costs of manufacturing goods. Historically, Super Micro has posted margins closer to 12% or higher, which helps explain the heavy selling pressure on the stock.
Context matters. The decline isn’t the result of inefficient factories or wasteful spending; it stems from a fierce pricing battle with Dell Technologies (NYSE: DELL). Both companies are aggressively competing to win large contracts from hyperscalers—the massive cloud and AI builders that are rapidly scaling their data centers.
To put the magnitude of these deals in perspective, one customer accounted for 63% of Super Micro’s revenue last quarter. To secure such contracts against a giant like Dell, Super Micro chose to sharply lower prices—a classic land-grab tactic.
Why Sacrifice Profit?
Accepting lower profits now can lock in a large and sticky customer base for the future. This strategy makes sense for three reasons:
- Stickiness: Once complex server racks and systems are installed, switching vendors is costly and disruptive.
- Scale: More than $12 billion in revenue in a single quarter provides the cash flow to expand manufacturing and logistics quickly.
- Duopoly potential: Aggressive pricing pressures smaller competitors out of the market, narrowing competition to a few large suppliers—principally Super Micro and Dell.
The Razor and Blade Model: Monetizing the Cooling
If servers are being sold at thin margins, where will the profits come from? The answer is a familiar business model: the razor-and-blade approach. Sell the base product cheaply (the server) and monetize the complementary, higher-margin products and services over time.
For Super Micro, the “blades” are its Data Center Building Block Solutions (DCBBS). The company is shifting beyond just selling server chassis to offering the full ecosystem required to operate them.
As AI accelerators from NVIDIA (NASDAQ: NVDA)and AMD (NASDAQ: AMD) grow more powerful, they generate enormous heat. Traditional air cooling can’t keep pace, pushing data centers toward Direct Liquid Cooling (DLC)—an area where Super Micro has expertise.
The Profit Pivot
While servers themselves may carry low margins today, the infrastructure required to cool and power them is significantly more profitable.
- The tech: Liquid cooling systems, coolant distribution units (CDUs), power distribution shelves, and management software.
- The margins: Management says DCBBS products have gross margins north of 20%.
- The growth opportunity: In the first half of the fiscal year, these solutions contributed roughly 4% of total profit; management expects to at least double that contribution by the end of calendar 2026.
This pivot is central to the bullish case: Super Micro has already installed the servers, and it is well positioned to upsell higher-margin cooling, power and management solutions to the same customers.
A $10 Billion Signal: Why Inventory Is Gold
Bearish investors have also flagged the company’s balance sheet, where inventory has swollen to $10.6 billion. In many businesses, large inventory can signal waning demand and the risk of markdowns.
But the AI hardware market is currently defined by scarcity—not surplus. There is a global shortage of advanced components, and having inventory on hand is a competitive advantage. Holding roughly $10 billion in ready-to-ship hardware allows Super Micro to fulfill orders faster than competitors waiting on parts. That speed-to-market is valuable for clients racing to deploy and iterate AI models.
The Roadmap Ahead
The inventory build also signals preparation for an upgrade cycle expected later in 2026:
- NVIDIA: The launch of the Vera Rubin platform.
- AMD: The rollout of Helios solutions.
These next-generation chips should trigger another wave of system replacements and expansions. By accumulating inventory now, Super Micro is positioned to ship updated systems immediately. Management has raised full-year revenue guidance to at least $40 billion, indicating confidence that this inventory will convert into sales rather than sit idle.
A Discounted Leader: Valuation Meets Opportunity
The easy-money phase of the AI hardware trade is over; the market has moved from hype to execution. Investors are demanding evidence that companies can manage costs while sustaining growth.
With shares depressed, Super Micro’s valuation looks more attractive relative to its growth. The price-to-earnings ratio has fallen to about 23x—a typical multiple for a steady manufacturing business—yet the company is delivering revenue that more than doubled year over year.
Analysts have taken note. Firms such as Rosenblatt Securities have maintained Buy ratings with price targets near $55, implying meaningful upside from the current ~$30 level.
Risks around margins and the costly competition with Dell are real. But the underlying growth story remains intact. Super Micro is building the physical backbone of the AI economy. For investors willing to look past short-term noise and wait for the higher-margin infrastructure strategy to play out, the current sell-off could represent a rare discount on an industry leader.
Wednesday’s Featured News
The Aging of America Could Make HCA Healthcare a Long-Term Winner
By Nathan Reiff. Publication Date: 3/8/2026.
Key Points
- HCA Healthcare has strong earnings growth, volume gains, and adjusted EBITDA gains, among other metrics, revealing strong fundamentals despite coming up short of analyst revenue estimates last quarter.
- The company’s 2026 guidance suggests room to grow in several areas, though threats remain.
- HCA’s recent rally may leave little room for short-term growth, but the stock could appeal to investors with longer-term healthcare demand trends in mind.
- Special Report: [Sponsorship-Ad-6-Format3]
Shifting demographics in the United States mean adults at retirement age or older will outnumber minors sometime in the coming decade, and that growing population will drive substantially higher healthcare spending. That shift creates a significant opportunity for investors who can take a long-term view and position themselves for an expected, multi-year increase in medical-care demand.
HCA Healthcare (NYSE: HCA) stands to be a primary beneficiary of this trend because of its large network of hospitals, surgery centers, urgent-care locations and other facilities. The company is already seeing robust demand and utilization, and investors focused on long-term sector dynamics may find HCA increasingly compelling.
A Mixed Earnings Report Masks Fundamental Strengths
Skip Headlines Straight to Original Research (Ad)
Our investment research analysts are going to be releasing their next investment idea tomorrow morning, around 10:00 AM Eastern time.Add yourself to the distribution list here.
HCA’s latest earnings report for Q4 2025 was mixed, similar to results reported by many other healthcare firms. The company comfortably beat analyst expectations for earnings per share (EPS), posting $8.01—an improvement of almost 29% versus the consensus of $7.37.
Revenue growth of 6.7% year over year (YOY), however, came in a bit softer than expected. Analysts had forecast quarterly revenue of $19.7 billion; HCA reported revenue roughly $158 million below that figure. The slower momentum reflected several headwinds, including policy shifts, the expiration of premium tax credits and changes in uninsured rates.
Despite those pressures, HCA’s results highlight important underlying strengths. The company recorded its 19th consecutive quarter of volume growth, adjusted EBITDA rose 11% YOY, and adjusted EBITDA margin expanded by 80 basis points. Patient utilization is at record levels—about 47 million patient encounters in 2025—helping to boost operating cash flow by roughly 20% for the full year.
Signs of Potential From HCA’s Guidance
HCA’s forward guidance may appeal to prospective investors. For 2026, management expects revenue of $76.5 billion to $80 billion and adjusted EBITDA of $15.55 billion to $16.45 billion. Diluted EPS is projected at $29.10 to $31.50.
The company also plans to deploy capital: it raised its 2026 CapEx outlook to as much as $5.5 billion and authorized a $10 billion share-repurchase program. Current shareholders are being rewarded with a higher payout as well—HCA increased its quarterly dividend by 8.3%, to $0.78 (a yield of about 0.54% and a payout ratio near 10.15%).
Management is banking on continued improvement in admissions to support the outlook. Same-facility admissions improved 2.4% YOY in the quarter, and same-facility revenue per equivalent admission rose 2.9%. For 2026, HCA expects equivalent admissions to increase another 2% to 3%.
The Risks Remaining For HCA
HCA’s momentum does not eliminate risks. Executives expect adjusted EBITDA to be pressured by an estimated $600 million to $900 million in 2026, in part due to changes to health insurance exchanges. State supplemental payments are another headwind: the company anticipates a $250 million to $450 million decline in supplemental net benefits for the year.
To counter these impacts, HCA has launched a $400 million resiliency program aimed at revenue integrity, capacity management and cost discipline—leveraging AI and digital investments where possible. How effective those initiatives will be remains to be seen.
Still, Wall Street appears reasonably confident in HCA’s ability to navigate a challenging environment. Analysts expect the company to grow earnings by more than 12% next year, and roughly two-thirds of the 25 analysts covering the stock currently rate it a Buy or equivalent. Several analysts have already raised price targets or reiterated bullish ratings in 2026.
Shares are up nearly 14% year-to-date in 2026, which may limit near-term upside. But as HCA positions itself for an anticipated long-term increase in healthcare demand, it could represent an attractive opportunity for long-term investors.
Thank you for subscribing to Earnings360, a morning newsletter that summarizes quarterly earnings for public companies that trade on U.S. markets.
This email content is a paid advertisement from Trend Labs, a third-party advertiser of Earnings360 and MarketBeat.
If you need help with your subscription, please contact our South Dakota based support team at contact@marketbeat.com.
If you no longer wish to receive email from Earnings360, you can unsubscribe.
Copyright 2006-2026 MarketBeat Media, LLC. All rights protected.
345 N Reid Pl. #620, Sioux Falls, S.D. 57103. USA..
From Our Partners: [How To] Invest Pre-IPO In SpaceX With $100! (From Paradigm Press)
RJ Hamster 